Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PBYI | AZN | AMGN | GILD | BMY |
| Company | Puma Biotechnology | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 7.44 | 184.53 | 329.13 | 133.38 | 57.23 |
| High | 7.70 | 185.61 | 332.98 | 136.75 | 57.40 |
| Low | 7.40 | 183.55 | 329.05 | 133.19 | 56.36 |
| Latest | 7.45 | 184.92 | 331.11 | 136.30 | 56.54 |
| Change | +0.10 | +3.68 | +1.52 | +2.82 | -0.41 |
| % Change | +1.36% | +2.03% | +0.46% | +2.11% | -0.73% |
| Volume | 484,433 | 1,613,797 | 2,589,062 | 6,104,796 | 9,077,406 |
| 20-Day Average Volume | 256,846 | 1,964,561 | 2,567,081 | 5,392,563 | 9,760,866 |
| Previous Close | 7.35 | 181.24 | 329.59 | 133.48 | 56.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.49 | 193.84 | 343.64 | 134.67 | 58.49 |
| 20-Day Raw Stochastic | 48.35% | 19.01% | 27.44% | 56.09% | 7.58% |
| 20-Day Relative Strength | 57.41 | 41.82 | 40.87 | 49.69 | 44.08 |
| Weighted Alpha | +96.99 | +29.70 | +18.55 | +33.88 | +21.92 |
| Today's Opinion | 88% Buy | 8% Buy | 8% Sell | 24% Buy | 24% Buy |
| Previous Opinion | 88% Buy | 8% Buy | 8% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 88% Buy | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/29/26 | -0.01% since 04/29/26 | -2.02% since 04/29/26 | +5.92% since 04/29/26 | -1.55% since 04/29/26 |
| Low | 7.11 on 05/05/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.96 on 04/30/26 | 56.36 on 05/06/26 |
| High | 7.70 on 05/06/26 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 136.65 on 05/06/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | +8.56% since 04/06/26 | -8.70% since 04/06/26 | -3.32% since 04/06/26 | -2.61% since 04/06/26 | -4.44% since 04/06/26 |
| Low | 6.61 on 04/07/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.36 on 05/06/26 |
| High | 7.90 on 04/10/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +7.78% since 02/06/26 | -4.06% since 02/06/26 | -13.82% since 02/06/26 | -10.51% since 02/06/26 | -8.54% since 02/06/26 |
| Low | 5.50 on 03/02/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 56.36 on 05/06/26 |
| High | 7.90 on 04/10/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +52.65% since 11/06/25 | +10.53% since 11/06/25 | +4.95% since 11/06/25 | +10.59% since 11/06/25 | +21.58% since 11/06/25 |
| Low | 4.57 on 11/11/25 | 168.44 on 11/07/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 7.90 on 04/10/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 374,056 | 281,086,560 | 177,874,784 | 165,678,304 | 116,295,952 |
| Shares Outstanding, K | 50,892 | 1,550,908 | 539,685 | 1,241,222 | 2,042,071 |
| Annual Sales | 228,370,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 31,110,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 75,450,000 | 15,288,000,000 | 8,618,000,000 | 7,925,000,000 | 11,489,000,000 |
| Last Quarter Net Income | 13,440,000 | 3,080,000,000 | 1,819,000,000 | 2,183,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.24 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.29 on 02/26/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/07/26 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 12.34 | 19.81 | 14.65 | 16.28 | 9.68 |